Biliary Stricture Clinical Trial
Official title:
Clinical Registry of Cholangioscopy Using the SpyGlass™ Direct Visualization System (DVS) Throughout the AMEA (Asia, Middle-East, Africa) Region
NCT number | NCT02281019 |
Other study ID # | 90947376 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | November 15, 2014 |
Est. completion date | October 18, 2016 |
Verified date | July 2019 |
Source | Boston Scientific Corporation |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational [Patient Registry] |
The purpose of this study is to document indications for cholangioscopy and clinical utility of the SpyGlass Direct Visualization System (DVS) throughout the AMEA (Asia, Middle-East, Africa) region when used per standard of practice.
Status | Completed |
Enrollment | 526 |
Est. completion date | October 18, 2016 |
Est. primary completion date | September 2016 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Age 18 or older. - Willing and able to provide written informed consent to participate in the study. - Willing and able to comply with the study procedures. - Indicated for ERCP and cholangioscopy or indicated for ERCP with suspected need for cholangioscopy. Exclusion Criteria: - Endoscopic techniques are contraindicated. - ERCP is contraindicated - A medical condition that warrants the use of the device outside of the indication for use. - Requirement for anticoagulation that cannot be safely stopped at least 7 days prior to the procedure. |
Country | Name | City | State |
---|---|---|---|
Australia | Royal Adelaide Hospital | Adelaide | |
Australia | Royal Brisbane and Women's Hospital | Herston | Queensland |
Australia | Royal Prince Alfred Hospital | Newtown | |
Hong Kong | Prince of Wales Hospital | Shatin | |
India | Postgraduate Institute of Medical Education & Research | Chandigarh | |
India | Medanta -The Medicity Institute of Digestive & Hepatobiliary Sciences | Gurgaon | |
India | Asian Institute of Gastroenterology | Hyderabad | |
India | Apollo Gleneagles Hospitals Kolkata | Kolkata | West Bengal |
India | Baldota Institute of Digestive Sciences | Parel | |
Japan | Teikyo University Mizonokuchi Hospital | Kawasaki | |
Japan | Kinki University School of Medicine | Osaka-sayama | |
Japan | Tokyo Medical University | Tokyo | |
Korea, Republic of | Soon Chun Hyang University Bucheon Hospital | Bucheon | |
Korea, Republic of | Asan Medical Center | Seoul | |
Korea, Republic of | Samsung Medical Center | Seoul | |
Pakistan | Civil Hospital- Karachi | Karachi | |
Saudi Arabia | King Khalid University Hospital | Riyadh | |
Singapore | Changi General Hospital Pte Ltd. | Singapore | |
South Africa | Netcare Unitas Hospital | Centurion | |
Thailand | King Chulalongkorn Memorial Hospital | Bangkok |
Lead Sponsor | Collaborator |
---|---|
Boston Scientific Corporation |
Australia, Hong Kong, India, Japan, Korea, Republic of, Pakistan, Saudi Arabia, Singapore, South Africa, Thailand,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Procedural success for indeterminate strictures or undefined filling defects | For indeterminate strictures or undefined filling defects cases procedural success is defined as 1) ability to visualize stricture or defect, and 2) ability to provide visual impression of malignancy, and 3) when applicable, ability to obtain SpyBite biopsy adequate for histology | Procedure - the average expected duration of the procedure is 1.5 hours | |
Primary | Procedural success for biliary stone cases | For biliary stone cases procedural success is defined as 1) ability to visualize the stone(s), and 2) ability to successfully initiate stone fragmentation, and 3) ability to achieve stone clearance in one or more SpyGlass procedures. | Procedure - the average expected duration of the procedure is 1.5 hours | |
Primary | Procedural success for other indications | For other indications procedural success is defined as ability to establish diagnosis and /or complete therapy in the following categories: 1) pre-operative assessment of extent of peri-ampullary and biliary tumors, 2) selective guidewire placement, 3) assessment of unexplained hemobilia, 4) assessment of portal biliopathy, 5) assessment of intraductal biliary ablation therapy, 6) extraction of migrated stents, or 7) other. | Procedure - the average expected duration of the procedure is 1.5 hours | |
Secondary | Evaluation of serious adverse events (SAEs) related to the SpyGlass devices and/or the SpyGlass procedure | Evaluation of serious adverse events (SAEs) related to the SpyGlass devices and/or the SpyGlass procedure from enrollment through the 72 Hour Post Procedure Follow-up Visit. | Procedure from enrollment through the 72 Hour Post Procedure Follow-up Visit | |
Secondary | Impact of SpyGlass procedure on suspected diagnosis based on prior ERCP | Procedure - the average expected duration of the procedure is 1.5 hours | ||
Secondary | Evaluation of impact of use of antibiotics on incidence of SAEs related to the device and/or procedure. | Procedure - the average expected duration of the procedure is 1.5 hours | ||
Secondary | For patients undergoing SpyBite biopsy: correlation between number of biopsies and conclusive histopathology of SpyBite biopsies. | Assessment Detail: Endpoint determined for all patients in whom SpyBite biopsy was taken and observed image features were reported. Observed image features include the following categories: None, Growth, Stricture, Hyperplasia, Ulceration, Mass, Dilated tortuous vessels, Papillary or villous projections, Intraductal nodules, Mucus. |
Procedure to 6 months | |
Secondary | For patients undergoing stone management: number of SpyGlass procedures needed to reach stone clearance. | Procedure - the average expected duration of the procedure is 1.5 hours | ||
Secondary | For patients undergoing stone management: correlation between stone size and ability to reach stone clearance in one SpyGlass session. | Procedure - the average expected duration of the procedure is 1.5 hours | ||
Secondary | For patients undergoing stone management: incidence of visualization of stones not suspected during previous ERCP. | Procedure - the average expected duration of the procedure is 1.5 hours |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03115411 -
Prospective Evaluation of Winged Biliary Stent Patency in Patients With Benign Biliary Obstruction
|
N/A | |
Completed |
NCT02041390 -
Effect of Short Message Service Intervention on Stent Removal/Exchange Adherence in Patients With Benign Pancreaticobiliary Diseases
|
N/A | |
Recruiting |
NCT01439698 -
Radio Frequency Ablation in the Management of Pancreatico-biliary Disorders: A Multicenter Registry
|
N/A | |
Terminated |
NCT01413386 -
Efficacy and Safety of the Paclitaxel Eluting Covered Biliary Stent to the Common Covered Metallic Biliary Stent
|
N/A | |
Completed |
NCT01543256 -
WallFlex Biliary Fully Covered (FC) Chronic Pancreatitis Study
|
N/A | |
Enrolling by invitation |
NCT04572711 -
Prospective Evaluation of Biliary Tissue Sampling With ERCP
|
||
Recruiting |
NCT03229655 -
Evaluation of Sequential Stent Addition vs. Incremental Dilation & Stent Exchange for Management of Anastomotic Biliary Strictures After Liver Transplantation
|
N/A | |
Completed |
NCT02916199 -
Primary Needle Knife Fistulotomy Versus Conventional Cannulation Method
|
N/A | |
Recruiting |
NCT01522573 -
T-EUS for Gastrointestinal Disorders: A Multicenter Registry
|
N/A | |
Recruiting |
NCT01524146 -
Photodynamic Therapy (PDT) Cholangiocarcinoma Registry
|
N/A | |
Recruiting |
NCT04010734 -
Primary Cholangioscopy Versus ERCP in the Diagnosis of Biliary Strictures
|
N/A | |
Not yet recruiting |
NCT06369896 -
Digital Single-operator Cholangioscopy and Intraductal Ultrasound for Nonicteric Biliary Strictures
|
||
Recruiting |
NCT04391153 -
FISH in Diagnosis of Biliary Stricture
|
N/A | |
Active, not recruiting |
NCT03997994 -
DIGEST I Drug Coated Balloon for Biliary Stricture
|
N/A | |
Enrolling by invitation |
NCT03951324 -
Volumetric Laser Endomicroscopy's (VLE) Diagnostic Accuracy Validation Study: Impact on Clinical Management Study
|
||
Unknown status |
NCT01085747 -
Endoscopic Treatment of Biliary Stricture Caused by Chronic Pancreatitis
|
N/A | |
Completed |
NCT02105181 -
Fully Covered Self-expandable Metal Stents (FCMS) in Benign Biliary Strictures
|
N/A | |
Recruiting |
NCT05761483 -
Endoscopic Management of Non-anastomotic Biliary Strictures Following Liver Transplantation.
|
||
Completed |
NCT03673033 -
Biliary Complications in Live Donor Liver Transplantation
|
||
Recruiting |
NCT06277531 -
Evaluation of diagnostiC Capacity of eccDNAs as Biomarkers in Indetermined biLiary Stricture(ECCBILE)
|